Crosspoint Capital Strategies’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Crosspoint Capital Strategies’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-700	Closed	-$12K	–	1021
2015 Q4	$12K	Buy	+700	New	+$12K	﹤0.01%	683

Crosspoint Capital Strategies's AVNR Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2016, closing a stake of 700 shares — an estimated $12K sold.

Crosspoint Capital Strategies first reported a position in AVNR in Q4 2015 and held it in 1 quarter. The position peaked at $12K in Q4 2015. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2016.

Crosspoint Capital Strategies reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2016 after selling out during the quarter.
Crosspoint Capital Strategies sold 700 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2016, an estimated $12K.
Crosspoint Capital Strategies first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2015 and held it in 1 quarter.
Crosspoint Capital Strategies's AVANIR PHARMACEUTICALS, INC CL A position peaked at $12K in Q4 2015.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.